Björnestedt R, Widersten M, Board P G, Mannervik B
Department of Biochemistry, Uppsala University, Sweden.
Biochem J. 1992 Mar 1;282 ( Pt 2)(Pt 2):505-10. doi: 10.1042/bj2820505.
Two chimaeric human-rat class Alpha glutathione transferases were constructed by fusion of DNA segments derived from the plasmids pTGT2-AT and pGTB38 and expression of the corresponding proteins in Escherichia coli. The recombinant proteins H1R1/1 and H1R1/2 encoded by plasmids pH1R1/1 and pH1R1/2 are composed of a segment of the human class Alpha subunit 1 from the N-terminus to His-143 and Pro-207 respectively, followed by the complementary C-terminal portion of the rat class Alpha subunit 1 sequence. Compared with the parental human enzyme, H1R1/1 is altered in 20 positions due to the introduction of 79 residues from the rat enzyme, while H1R1/2 is altered in five positions out of 15 in the C-terminal region. The design of mutant H1R1/1 is equivalent to introduction of exons 6 and 7 of the rat subunit 1 gene in place of the homologous human nucleotide sequence. The two chimaeric proteins are enzymatically active with several substrates, even though the activity in most cases is somewhat decreased in comparison with the wild-type human enzyme. Inhibition studies show that the kinetic properties mimic those of the human enzyme, indicating that the N-terminal two-thirds of the primary structure plays the major role in governing the catalytic properties. The results of this study demonstrate that recombination of segments of primary structure between homologous enzymes may serve as a useful cassette technique for design of novel catalytically active proteins.
通过融合源自质粒pTGT2 - AT和pGTB38的DNA片段,并在大肠杆菌中表达相应蛋白质,构建了两种嵌合的人 - 大鼠α类谷胱甘肽转移酶。质粒pH1R1/1和pH1R1/2编码的重组蛋白H1R1/1和H1R1/2分别由人α类亚基1从N端到His - 143和Pro - 207的一段序列组成,随后是大鼠α类亚基1序列的互补C端部分。与亲本人类酶相比,H1R1/1由于引入了大鼠酶的79个残基而在20个位置发生改变,而H1R1/2在C端区域的15个位置中有5个位置发生改变。突变体H1R1/1的设计相当于用大鼠亚基1基因的外显子6和7取代同源的人类核苷酸序列。这两种嵌合蛋白对几种底物具有酶活性,尽管在大多数情况下与野生型人类酶相比活性有所降低。抑制研究表明,其动力学特性模拟了人类酶的动力学特性,表明一级结构的N端三分之二在决定催化特性方面起主要作用。本研究结果表明,同源酶之间一级结构片段的重组可作为一种有用的盒式技术,用于设计新型催化活性蛋白。